Efranat efranat.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Efranat develops a unique anti-cancer immunotherapy treatment based on a natural plasma protein molecule named GcMAF. The concept underlying the technology is to engage the body's own immune system and harness it against cancer. GcMAF is a very potent immunomodulator that activates macrophages, a group of white blood cells that play key role in the immune system's defense against cancer. Efranat's GcMAF is manufactured and processed under GMP in a procedure that mimics the natural process in the...Show all

Efranat develops a unique anti-cancer immunotherapy treatment based on a natural plasma protein molecule named GcMAF. The concept underlying the technology is to engage the body's own immune system and harness it against cancer. GcMAF is a very poten...Show all

Company (Alive / Active)

Phone: + 972 8 9724972

Fax:

7 Oppenheimer st

Rehovot, 76701
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Efranat $4.5M Nov 18, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Efranat Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.